FOXM1 and non-small cell lung carcinoma: In EGFR-mutant NSCLC, FOXM1 rs3742076_G (rs3742076) was found to confer gefitinib resistance by increasing FOXM1 protein stability through activating Wnt/β-catenin signaling pathway [20] (Table 4).